Lacosamide
Lacosamide (INN, formerly known as erlosamide, harkeroside, SPM 927, or ADD 234037), is a medicat ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Etravirine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 25 mg Tablets 1.2.3 100 mg Tablets 1.2.4 200 mg Tablets 1.3 Market by Application 1.3.1 Global Etravirine Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Adults 1.3.3 Pediatric patients 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Etravirine Market Perspective (2016-2027) 2.2 Etravirine Growth Trends by Regions 2.2.1 Etravirine Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Etravirine Historic Market Share by Regions (2016-2021) 2.2.3 Etravirine Forecasted Market Size by Regions (2022-2027) 2.3 Etravirine Industry Dynamic 2.3.1 Etravirine Market Trends 2.3.2 Etravirine Market Drivers 2.3.3 Etravirine Market Challenges 2.3.4 Etravirine Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Etravirine Players by Revenue 3.1.1 Global Top Etravirine Players by Revenue (2016-2021) 3.1.2 Global Etravirine Revenue Market Share by Players (2016-2021) 3.2 Global Etravirine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Etravirine Revenue 3.4 Global Etravirine Market Concentration Ratio 3.4.1 Global Etravirine Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Etravirine Revenue in 2020 3.5 Etravirine Key Players Head office and Area Served 3.6 Key Players Etravirine Product Solution and Service 3.7 Date of Enter into Etravirine Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Etravirine Breakdown Data by Type 4.1 Global Etravirine Historic Market Size by Type (2016-2021) 4.2 Global Etravirine Forecasted Market Size by Type (2022-2027) 5 Etravirine Breakdown Data by Application 5.1 Global Etravirine Historic Market Size by Application (2016-2021) 5.2 Global Etravirine Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Etravirine Market Size (2016-2027) 6.2 North America Etravirine Market Size by Type 6.2.1 North America Etravirine Market Size by Type (2016-2021) 6.2.2 North America Etravirine Market Size by Type (2022-2027) 6.2.3 North America Etravirine Market Size by Type (2016-2027) 6.3 North America Etravirine Market Size by Application 6.3.1 North America Etravirine Market Size by Application (2016-2021) 6.3.2 North America Etravirine Market Size by Application (2022-2027) 6.3.3 North America Etravirine Market Size by Application (2016-2027) 6.4 North America Etravirine Market Size by Country 6.4.1 North America Etravirine Market Size by Country (2016-2021) 6.4.2 North America Etravirine Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Etravirine Market Size (2016-2027) 7.2 Europe Etravirine Market Size by Type 7.2.1 Europe Etravirine Market Size by Type (2016-2021) 7.2.2 Europe Etravirine Market Size by Type (2022-2027) 7.2.3 Europe Etravirine Market Size by Type (2016-2027) 7.3 Europe Etravirine Market Size by Application 7.3.1 Europe Etravirine Market Size by Application (2016-2021) 7.3.2 Europe Etravirine Market Size by Application (2022-2027) 7.3.3 Europe Etravirine Market Size by Application (2016-2027) 7.4 Europe Etravirine Market Size by Country 7.4.1 Europe Etravirine Market Size by Country (2016-2021) 7.4.2 Europe Etravirine Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Etravirine Market Size (2016-2027) 8.2 Asia-Pacific Etravirine Market Size by Type 8.2.1 Asia-Pacific Etravirine Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Etravirine Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Etravirine Market Size by Type (2016-2027) 8.3 Asia-Pacific Etravirine Market Size by Application 8.3.1 Asia-Pacific Etravirine Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Etravirine Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Etravirine Market Size by Application (2016-2027) 8.4 Asia-Pacific Etravirine Market Size by Region 8.4.1 Asia-Pacific Etravirine Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Etravirine Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Etravirine Market Size (2016-2027) 9.2 Latin America Etravirine Market Size by Type 9.2.1 Latin America Etravirine Market Size by Type (2016-2021) 9.2.2 Latin America Etravirine Market Size by Type (2022-2027) 9.2.3 Latin America Etravirine Market Size by Type (2016-2027) 9.3 Latin America Etravirine Market Size by Application 9.3.1 Latin America Etravirine Market Size by Application (2016-2021) 9.3.2 Latin America Etravirine Market Size by Application (2022-2027) 9.3.3 Latin America Etravirine Market Size by Application (2016-2027) 9.4 Latin America Etravirine Market Size by Country 9.4.1 Latin America Etravirine Market Size by Country (2016-2021) 9.4.2 Latin America Etravirine Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Etravirine Market Size (2016-2027) 10.2 Middle East & Africa Etravirine Market Size by Type 10.2.1 Middle East & Africa Etravirine Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Etravirine Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Etravirine Market Size by Type (2016-2027) 10.3 Middle East & Africa Etravirine Market Size by Application 10.3.1 Middle East & Africa Etravirine Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Etravirine Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Etravirine Market Size by Application (2016-2027) 10.4 Middle East & Africa Etravirine Market Size by Country 10.4.1 Middle East & Africa Etravirine Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Etravirine Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Janssen Therapeutics 11.1.1 Janssen Therapeutics Company Details 11.1.2 Janssen Therapeutics Business Overview 11.1.3 Janssen Therapeutics Etravirine Introduction 11.1.4 Janssen Therapeutics Revenue in Etravirine Business (2016-2021) 11.1.5 Janssen Therapeutics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Etravirine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of 25 mg Tablets Table 3. Key Players of 100 mg Tablets Table 4. Key Players of 200 mg Tablets Table 5. Global Etravirine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Etravirine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Etravirine Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Etravirine Market Share by Regions (2016-2021) Table 9. Global Etravirine Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Etravirine Market Share by Regions (2022-2027) Table 11. Etravirine Market Trends Table 12. Etravirine Market Drivers Table 13. Etravirine Market Challenges Table 14. Etravirine Market Restraints Table 15. Global Etravirine Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Etravirine Market Share by Players (2016-2021) Table 17. Global Top Etravirine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Etravirine as of 2020) Table 18. Ranking of Global Top Etravirine Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Etravirine Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Etravirine Product Solution and Service Table 22. Date of Enter into Etravirine Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Etravirine Market Size by Type (2016-2021) (US$ Million) Table 25. Global Etravirine Revenue Market Share by Type (2016-2021) Table 26. Global Etravirine Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Etravirine Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Etravirine Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Etravirine Revenue Market Share by Application (2016-2021) Table 30. Global Etravirine Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Etravirine Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Etravirine Market Size by Type (2016-2021) (US$ Million) Table 33. North America Etravirine Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Etravirine Market Size by Application (2016-2021) (US$ Million) Table 35. North America Etravirine Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Etravirine Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Etravirine Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Etravirine Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Etravirine Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Etravirine Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Etravirine Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Etravirine Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Etravirine Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Etravirine Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Etravirine Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Etravirine Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Etravirine Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Etravirine Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Etravirine Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Etravirine Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Etravirine Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Etravirine Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Etravirine Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Etravirine Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Etravirine Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Etravirine Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Etravirine Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Etravirine Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Etravirine Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Etravirine Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Etravirine Market Size by Country (2022-2027) & (US$ Million) Table 62. Janssen Therapeutics Company Details Table 63. Janssen Therapeutics Business Overview Table 64. Janssen Therapeutics Etravirine Product Table 65. Janssen Therapeutics Revenue in Etravirine Business (2016-2021) & (US$ Million) Table 66. Janssen Therapeutics Recent Development Table 67. Research Programs/Design for This Report Table 68. Key Data Information from Secondary Sources Table 69. Key Data Information from Primary Sources List of Figures Figure 1. Global Etravirine Market Share by Type: 2020 VS 2027 Figure 2. 25 mg Tablets Features Figure 3. 100 mg Tablets Features Figure 4. 200 mg Tablets Features Figure 5. Global Etravirine Market Share by Application: 2020 VS 2027 Figure 6. Adults Case Studies Figure 7. Pediatric patients Case Studies Figure 8. Etravirine Report Years Considered Figure 9. Global Etravirine Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Etravirine Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Etravirine Market Share by Regions: 2020 VS 2027 Figure 12. Global Etravirine Market Share by Regions (2022-2027) Figure 13. Global Etravirine Market Share by Players in 2020 Figure 14. Global Top Etravirine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Etravirine as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Etravirine Revenue in 2020 Figure 16. Global Etravirine Revenue Market Share by Type (2016-2021) Figure 17. Global Etravirine Revenue Market Share by Type (2022-2027) Figure 18. North America Etravirine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Etravirine Market Share by Type (2016-2027) Figure 20. North America Etravirine Market Share by Application (2016-2027) Figure 21. North America Etravirine Market Share by Country (2016-2027) Figure 22. United States Etravirine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Etravirine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Etravirine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Etravirine Market Share by Type (2016-2027) Figure 26. Europe Etravirine Market Share by Application (2016-2027) Figure 27. Europe Etravirine Market Share by Country (2016-2027) Figure 28. Germany Etravirine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Etravirine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Etravirine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Etravirine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Etravirine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Etravirine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Etravirine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Etravirine Market Share by Type (2016-2027) Figure 36. Asia-Pacific Etravirine Market Share by Application (2016-2027) Figure 37. Asia-Pacific Etravirine Market Share by Region (2016-2027) Figure 38. China Etravirine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Etravirine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Etravirine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Etravirine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Etravirine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Etravirine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Etravirine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Etravirine Market Share by Type (2016-2027) Figure 46. Latin America Etravirine Market Share by Application (2016-2027) Figure 47. Latin America Etravirine Market Share by Country (2016-2027) Figure 48. Mexico Etravirine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Etravirine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Etravirine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Etravirine Market Share by Type (2016-2027) Figure 52. Middle East & Africa Etravirine Market Share by Application (2016-2027) Figure 53. Middle East & Africa Etravirine Market Share by Country (2016-2027) Figure 54. Turkey Etravirine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Etravirine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Etravirine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Janssen Therapeutics Revenue Growth Rate in Etravirine Business (2016-2021) Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed
Janssen Therapeutics
Lacosamide (INN, formerly known as erlosamide, harkeroside, SPM 927, or ADD 234037), is a medicat ... Read More
Entereg (alvimopan) is the first and only FDA-approved agent indicated to accelerate the time to ... Read More
Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vo ... Read More
Plerixafor (INN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoieti ... Read More